Additional Information

Description

Exparel 1.3% 10mL is a specialized liposome injection formulation containing bupivacaine, an amide-based local anesthetic. It is specifically designed for single-dose infiltration into surgical sites to provide prolonged postsurgical pain relief. This formulation utilizes liposomal encapsulation to extend the release of bupivacaine over time, enhancing its duration of action compared to traditional local anesthetics.

Each carton of Exparel contains 10 vials, ensuring healthcare providers have an ample supply for various surgical procedures requiring extended pain management strategies. The use of liposomes allows for controlled and sustained release of bupivacaine, effectively reducing the need for additional analgesics postoperatively and potentially improving patient outcomes by minimizing discomfort.

Exparel is administered directly into the surgical site by healthcare professionals trained in infiltration techniques. Its localized action targets pain receptors, providing targeted pain relief without affecting systemic circulation to the same extent as systemic pain medications. This localized approach helps to minimize systemic side effects commonly associated with traditional pain management methods.